RCM
AGN

Riverhead Capital Management’s Allergan plc AGN Stock Holding History

Riverhead Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$763K Sell
4,534
-27,565
-86% -$4.49M 0.03% 564
2019
Q2 		$5.37M Sell
32,099
-14,311
-31% -$1.98M 0.2% 134
2019
Q1 		$6.79M Buy
46,410
+17,042
+58% +$2.47M 0.28% 87
2018
Q4 		$3.92M Buy
29,368
+17,450
+146% +$2.86M 0.18% 158
2018
Q3 		$2.27M Sell
11,918
-3,000
-20% -$551K 0.08% 296
2018
Q2 		$2.49M Buy
14,918
+2,882
+24% +$463K 0.1% 269
2018
Q1 		$2.02M Buy
12,036
+6,871
+133% +$1.15M 0.09% 279
2017
Q4 		$845K Buy
5,165
+447
+9% +$80.2K 0.04% 479
2017
Q3 		$967K Buy
4,718
+67
+1% +$15.6K 0.05% 413
2017
Q2 		$1.13M Sell
4,651
-1,211
-21% -$285K 0.06% 360
2017
Q1 		$1.4M Buy
5,862
+894
+18% +$208K 0.08% 306
2016
Q4 		$1.04M Sell
4,968
-700
-12% -$145K 0.06% 338
2016
Q3 		$1.3M Sell
5,668
-13,080
-70% -$3.2M 0.08% 288
2016
Q2 		$1.3M Sell
18,748
-11,933
-39% -$2.75M 0.04% 378
2016
Q1 		$8.22M Sell
30,681
-40,050
-57% -$11.5M 0.12% 226
2015
Q4 		$22.1M Sell
70,731
-32,007
-31% -$9.53M 0.32% 72
2015
Q3 		$27.9M Buy
102,738
+45,226
+79% +$13.9M 0.44% 57
2015
Q2 		$17.5M Buy
57,512
+27,068
+89% +$8.07M 0.26% 108
2015
Q1 		$9.06M Sell
30,444
-452
-1% -$129K 0.14% 226
2014
Q4 		$7.95M Buy
30,896
+1,977
+7% +$494K 0.12% 238
2014
Q3 		$6.98M Buy
28,919
+6,903
+31% +$1.54M 0.12% 240
2014
Q2 		$4.91M Buy
22,016
+6,450
+41% +$1.34M 0.09% 277
2014
Q1 		$3.21M Buy
15,566
+303
+2% +$60K 0.07% 313
2013
Q4 		$2.56M Buy
+15,263
New +$2.39M 0.07% 309
2013
Q3 		– Sell
-6,000
Closed -$757K – 446
2013
Q2 		$757K Buy
+6,000
New +$679K 0.03% 374

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Riverhead Capital Management's AGN Position: Q3 2019 in Review

Riverhead Capital Management reduced its Allergan plc (AGN) stake by 86% in Q3 2019, selling an estimated $4.49M and leaving 4,534 shares worth $763K. The position accounts for 0.03% of the portfolio, ranked #564.

Riverhead Capital Management first reported a position in AGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $27.9M in Q3 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Riverhead Capital Management held 4,534 shares of Allergan plc worth $763K as of Q3 2019.
  • Riverhead Capital Management sold 27,565 Allergan plc shares in Q3 2019, an estimated $4.49M.
  • Allergan plc made up 0.03% of Riverhead Capital Management's portfolio in Q3 2019, its #564 holding.
  • Riverhead Capital Management first reported a position in Allergan plc in Q2 2013 and has held it in 25 quarters since.
  • Riverhead Capital Management's Allergan plc position peaked at $27.9M in Q3 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.